Cited by 62Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers

Open access
van den Broek, Irene, Fu, Qin, Kushon, Stuart, Kowalski, Michael P., Millis, Kevin, Percy, Andrew, Holewinski, Ronald J., Venkatraman, Vidya +1 more·2017·Clinical Mass Spectrometry

Abstract

Volumetric absorptive micro sampling (VAMS™) allows accurate sampling of 10 µL of blood from a minimally invasive finger prick and could enable remote personalized health monitoring. Moreover, VAMS overcomes effects from hematocrit and sample heterogeneity associated with dried blood spots (DBS). We describe the first application of VAMS with the Mitra® microsampling device for the quantification of protein biomarkers using an automated, high-throughput sample preparation method coupled with mass spectrometric (MS) detection. The analytical performance of the developed workflow was evaluated for 10 peptides from six clinically relevant proteins: apolipoproteins A-I, B, C-I, C-III, E, and human serum albumin (HSA). Extraction recovery from blood with three different levels of hematocrit varied between 100% and 111% for all proteins. Within-day and total assay reproducibility (i.e., 5 replicates on 5 days) ranged between 3.2-10.4% and 3.4-12.6%, respectively. In addition, after 22 weeks of storage of the Mitra microsampling devices at -80 °C, all peptide responses were within ±15% deviation from the initial response. Application to data-independent acquisition (DIA) MS further demonstrated the potential for broad applicability and the general robustness of the automated workflow by reproducible detection of 1661 peptides from 423 proteins (average 15.7%CV (n = 3) in peptide abundance), correlating to peptide abundances in corresponding plasma (R = 0.8383). In conclusion, we have developed an automated workflow for efficient extraction, digestion, and MS analysis of a variety of proteins in a fixed small volume of dried blood (i.e., 10 µL). This robust and high-throughput workflow will create manifold opportunities for the application of remote, personalized disease biomarker monitoring.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clinms.2017.08.004

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Volumetric absorptive micro-sampling (VAMS) blood collection devices allow patients to mail samples from home to analytical labs to undertake SRM/MRM/PRM assays quantifying cardiovascular disease risk-associated apolipoproteins or other markers.

    “Likewise, volumetric absorptive micro-sampling VAMS blood collection devices (e.g., Mitra devices or dried blood spots) allow patients to mail samples from home to analytical labs to undertake SRM/MRM/PRM assays quantifying CVD risk-associated apolipoproteins130 or other markers131.”

    From A high-stringency blueprint of the human proteome (2020) · cites this paper as [130]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Anderson, 2016, Bioanalysis
  2. Razavi, 2016, Bioanalysis, 8
  3. Gillet, 2012, Mol Cell Proteomics, 11, 016717

Cited by

Sorted by citations

Authors
van den Broek, I., Fu, Q., Kushon, S., Kowalski, M. P., Millis, K., Percy, A., Holewinski, R. J., Venkatraman, V., & Van Eyk, J. E.
Affiliations
  • Cedars-Sinai Medical Center (US)
  • Cambridge Isotope Laboratories, Inc. (United States) (US)
Venue
Clinical Mass Spectrometry
Published
2017-04
Volume
4-5
Pages
25-33
ISSN
  • 2213-8005 (ISSN-L)
  • 2376-9998
OpenAlex
W2752931564
Cited by
62
References
36
Citations by year
2026: 7 · 2025: 8 · 2024: 10 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 1
FWCI
1.89
Type
journal article
Language
en
Open access
Locations
  • Clinical mass spectrometry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (1R01HL111362-01A1)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
volumetric absorptive microsampling, dried blood spots, finger prick blood sampling, circulating protein biomarkers, apolipoproteins, human serum albumin, hematocrit effect, automated sample preparation, data-independent acquisition, remote patient monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review